Research in Indiana

Innovative Oncology Medicines Have Led to Impressive Gains in Patient Survivorship

WASHINGTON, D.C. (May 31, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani released the following statement highlighting the value of innovative cancer medicines for patients, the economy and the U.S. health care system:

A Day In The Life

PhRMA Clinical Trial Principles Strengthen Authorship Standards

Washington, D.C. (September 18, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson issued the following statement today regarding efforts to enhance transparency in clinical research:

PhRMA Statement on 2013 Special 301 Report

WASHINGTON, D.C. (May 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) International Vice President Jay Taylor issued the following statement today:

PhRMA Statement on Decision of the European General Court on EMA Disclosure of Company Data

WASHINGTON, D.C. (April 30, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matt Bennett issued the following statement today:

Nearly 200 Medicines in Development for Mental Illnesses

Washington, D.C. (July 12, 2012) — America’s biopharmaceutical research companies are developing 187 innovative medicines to help the nearly 60 million patients in the United States who are suffering from some form of mental illness.

Research in Maine

America’s Biopharmaceutical Companies’ Commitment to Research Remains Strong Despite Challenges

Washington, D.C. (April 11, 2013) — Investment in research and development (R&D) by member companies of the Pharmaceutical Research and Manufacturers of America (PhRMA) remained strong at an estimated $48.5 billion in 2012, despite economic, scientific, and business challenges. These efforts are highlighted in PhRMA’s 2013 Biopharmaceutical Research Industry Profile released today.

Biopharmaceuticals in Perspective: Chart Pack 2013

Pages

Subscribe to RSS - Innovation